Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| B cell | 43 studies | 48% ± 21% | |
| memory B cell | 20 studies | 55% ± 16% | |
| naive B cell | 20 studies | 54% ± 13% | |
| plasma cell | 15 studies | 31% ± 16% | |
| oligodendrocyte precursor cell | 11 studies | 36% ± 13% | |
| microglial cell | 10 studies | 32% ± 19% | |
| ciliated cell | 9 studies | 27% ± 12% | |
| glutamatergic neuron | 9 studies | 45% ± 24% | |
| retinal rod cell | 8 studies | 53% ± 26% | |
| retinal cone cell | 7 studies | 60% ± 23% | |
| GABAergic neuron | 7 studies | 51% ± 19% | |
| neuron | 6 studies | 31% ± 14% | |
| endothelial cell | 6 studies | 31% ± 18% | |
| epithelial cell | 6 studies | 39% ± 14% | |
| interneuron | 6 studies | 45% ± 19% | |
| astrocyte | 6 studies | 33% ± 17% | |
| macrophage | 5 studies | 37% ± 17% | |
| immature B cell | 5 studies | 64% ± 10% | |
| pericyte | 5 studies | 22% ± 7% | |
| plasmablast | 4 studies | 29% ± 12% | |
| retinal bipolar neuron | 4 studies | 27% ± 7% | |
| granule cell | 4 studies | 30% ± 18% | |
| precursor B cell | 4 studies | 34% ± 10% | |
| endothelial cell of lymphatic vessel | 4 studies | 21% ± 6% | |
| fibroblast | 4 studies | 23% ± 8% | |
| brush cell | 4 studies | 33% ± 9% | |
| smooth muscle cell | 4 studies | 24% ± 8% | |
| abnormal cell | 4 studies | 48% ± 22% | |
| GABAergic interneuron | 3 studies | 43% ± 13% | |
| glial cell | 3 studies | 29% ± 8% | |
| squamous epithelial cell | 3 studies | 39% ± 23% | |
| GABAergic amacrine cell | 3 studies | 24% ± 10% | |
| OFF-bipolar cell | 3 studies | 45% ± 12% | |
| ON-bipolar cell | 3 studies | 43% ± 12% | |
| glycinergic amacrine cell | 3 studies | 21% ± 6% | |
| rod bipolar cell | 3 studies | 35% ± 15% | |
| Schwann cell | 3 studies | 46% ± 24% | |
| basal cell | 3 studies | 30% ± 2% | |
| germinal center B cell | 3 studies | 31% ± 7% | |
| hepatocyte | 3 studies | 67% ± 19% | |
| myofibroblast cell | 3 studies | 27% ± 7% | |
| goblet cell | 3 studies | 43% ± 33% | |
| IgG plasma cell | 3 studies | 27% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 100% | 1698.01 | 245 / 245 | 99% | 11.17 | 496 / 502 |
| liver | 100% | 2308.17 | 226 / 226 | 98% | 18.47 | 398 / 406 |
| esophagus | 100% | 2152.97 | 1442 / 1445 | 97% | 16.96 | 177 / 183 |
| intestine | 100% | 3148.92 | 965 / 966 | 96% | 11.86 | 506 / 527 |
| thymus | 100% | 1192.33 | 651 / 653 | 94% | 8.80 | 566 / 605 |
| uterus | 99% | 1705.57 | 169 / 170 | 93% | 14.67 | 428 / 459 |
| stomach | 96% | 1026.18 | 344 / 359 | 95% | 13.07 | 273 / 286 |
| pancreas | 92% | 703.12 | 302 / 328 | 99% | 13.41 | 176 / 178 |
| skin | 100% | 3106.12 | 1808 / 1809 | 90% | 14.02 | 426 / 472 |
| ovary | 100% | 2921.06 | 180 / 180 | 90% | 8.99 | 385 / 430 |
| breast | 93% | 1405.24 | 429 / 459 | 95% | 33.80 | 1059 / 1118 |
| lung | 91% | 729.91 | 528 / 578 | 97% | 12.97 | 1118 / 1155 |
| kidney | 100% | 1234.03 | 89 / 89 | 87% | 7.49 | 787 / 901 |
| bladder | 90% | 1188.90 | 19 / 21 | 96% | 11.87 | 483 / 504 |
| brain | 82% | 797.35 | 2164 / 2642 | 88% | 8.09 | 621 / 705 |
| adrenal gland | 100% | 1648.58 | 258 / 258 | 44% | 3.12 | 102 / 230 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 36.15 | 29 / 29 |
| spleen | 100% | 4725.62 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 5.40 | 1 / 1 |
| adipose | 94% | 1060.03 | 1132 / 1204 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 91% | 11.51 | 41 / 45 |
| peripheral blood | 85% | 1388.14 | 792 / 929 | 0% | 0 | 0 / 0 |
| heart | 80% | 644.74 | 689 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 66% | 5.51 | 53 / 80 |
| blood vessel | 19% | 126.41 | 256 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 12% | 61.39 | 96 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0007265 | Biological process | Ras protein signal transduction |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005085 | Molecular function | guanyl-nucleotide exchange factor activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | RALGPS2 |
| Protein name | Ral GEF with PH domain and SH3 binding motif 2 Ras-specific guanine nucleotide-releasing factor RalGPS2 (Ral GEF with PH domain and SH3-binding motif 2) (RalA exchange factor RalGPS2) |
| Synonyms | |
| Description | FUNCTION: Guanine nucleotide exchange factor for the small GTPase RALA. May be involved in cytoskeletal organization. May also be involved in the stimulation of transcription in a Ras-independent fashion (By similarity). . |
| Accessions | Q86X27 ENST00000415888.1 H7C2H2 A0A0A0MR31 ENST00000367635.8 [Q86X27-1] H0Y338 ENST00000324778.5 ENST00000367634.7 [Q86X27-3] ENST00000367632.2 |